Viewing Study NCT00906061

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:04 PM
Ignite Modification Date: 2026-01-29 @ 12:56 PM
Study NCT ID: NCT00906061
Status: UNKNOWN
Last Update Posted: 2009-05-21
First Post: 2009-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
Sponsor: Hospital Arnau de Vilanova
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small-Cell Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Carcinoma, Small Cell View
None Lung Neoplasms View
None Docetaxel View
None Gemcitabine View
None ECOG 2 View